The Rheumatoid Arthritis Quality AH1_V Life Questionnaire    RAQoL    IH1_Z AH0 D_IH0_Z_IY1_Z S_P_AH0_S_IH1_F_IH0_K P_EY1_SH_AH0_N_T R_IY2_P_AO1_R_T_AH0_D AW1_T_K_AH2_M M_EH1_ZH_ER0 W_IH1_CH D_AH0_T_ER1_M_AH0_N_Z DH_AH0 IH0_F_EH1_K_T R_UW1_M_AH0_T_OY2_D AA0_R_TH_R_AY1_T_AH0_S HH_AE1_Z AA1_N AH0 P_EY1_SH_AH0_N_T EH1_S K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    The RAQoL HH_AE1_Z 30 AY1_T_AH0_M_Z W_IH1_DH AH0 Y_EH1_S AH0_N_D N_OW1 R_IH0_S_P_AA1_N_S F_AO1_R_M_AE2_T    AH0_N_D T_EY1_K_S AH0_B_AW1_T S_IH1_K_S M_IH1_N_AH0_T_S T_UW1 K_AH0_M_P_L_IY1_T    Scores AA1_N DH_AH0 RAQoL AA1_R AH0 S_AH1_M AH1_V AO1_L DH_AH0 IH2_N_D_AH0_V_IH1_JH_AH0_W_AH0_L AY1_T_AH0_M S_K_AO1_R_Z W_IH1_DH AH0 R_EY1_N_JH F_R_AH1_M 30    W_IH1_DH AH0 L_OW1_ER0 S_K_AO1_R IH1_N_D_AH0_K_EY2_T_IH0_NG B_EH1_T_ER0 K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    The RAQoL IH1_Z AH0 S_EH1_L_F AH0_S_EH1_S_M_AH0_N_T K_W_EH2_S_CH_AH0_N_EH1_R    M_IY1_N_IH0_NG P_EY1_SH_AH0_N_T_S F_IH1_L AW1_T DH_AH0 S_ER0_V_EY1 DH_EH0_M_S_EH1_L_V_Z IH0_N AO1_R_D_ER0 T_UW1 AH0_V_OY1_D IH0_K_S_P_EH2_R_IH0_M_EH1_N_T_AH0_L EH1_R_ER0    The RAQoL W_AA1_Z D_IH0_V_EH1_L_AH0_P_T B_AY1 Galen Research    DH_AH0 University AH1_V Leeds AH0_N_D DH_AH0 Academic Hospital Maastricht    AH0_N_D W_AA1_Z F_ER1_S_T P_AH1_B_L_IH0_SH_T IH0_N 1997    It W_AA1_Z DH_AH0 F_ER1_S_T P_EY1_SH_AH0_N_T K_AH0_M_P_L_IY1_T_AH0_D K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F K_W_EH2_S_CH_AH0_N_EH1_R DH_AE1_T F_OW1_K_AH0_S_T AA1_N R_UW1_M_AH0_T_OY2_D AA0_R_TH_R_AY1_T_AH0_S     AH0_N_D IH1_Z D_IH0_S_T_IH1_NG_K_T F_R_AH1_M AH1_DH_ER0 K_W_EH2_S_CH_AH0_N_EH1_R_Z AE1_Z IH1_T IH2_N_K_L_UW1_D_Z F_IH1_Z_IH0_K_AH0_L K_AA1_N_T_AE2_K_T AE1_Z AH0 D_IH0_M_EH1_N_SH_AH0_N AH1_V K_W_AA1_L_AH0_T_IY0 AH1_V L_AY1_F    Other D_IH0_M_EH1_N_SH_AH0_N_Z IH2_N_K_L_UW1_D AE0_K_T_IH1_V_IH0_T_IY0_Z AH1_V D_EY1_L_IY0 L_IH1_V_IH0_NG    S_OW1_SH_AH0_L IH2_N_T_ER0_AE1_K_SH_AH0_N F_AH1_NG_K_SH_AH0_N    IH0_M_OW1_SH_AH0_N_Z    M_UW1_D AH0_N_D R_EH2_K_R_IY0_EY1_SH_AH0_N AH0_N_D P_AE1_S_T_AY2_M_Z    Since IH1_T_S D_IH0_V_EH1_L_AH0_P_M_AH0_N_T    DH_AH0 RAQOL HH_AE1_Z B_IH1_N T_R_AE0_N_Z_L_EY1_T_AH0_D IH1_N_T_UW0 33 L_AE1_NG_G_W_AH0_JH_AH0_Z AH1_DH_ER0 DH_AE1_N Dutch AH0_N_D UK English    Validation S_T_AH1_D_IY0_Z HH_AE1_V B_IH1_N P_ER0_F_AO1_R_M_D IH0_N K_AH1_N_T_R_IY0_Z S_AH1_CH AE1_Z Sweden     Argentina    AH0_N_D Australia    IH0_N AO1_R_D_ER0 T_UW1 K_AH0_N_F_ER1_M DH_AH0 R_IH0_S_P_AA1_N_S_IH0_V_N_AH0_S AH0_N_D V_AH0_L_IH1_D_IH0_T_IY0 AH1_V DH_AH0 L_AE1_NG_G_W_AH0_JH AE2_D_AE0_P_T_EY1_SH_AH0_N_Z The RAQoL HH_AE1_Z B_IH1_N Y_UW1_Z_D IH0_N K_L_IH1_N_AH0_K_AH0_L S_T_AH1_D_IY0_Z IH0_N AO1_R_D_ER0 T_UW1 K_AH0_N_F_ER1_M DH_AH0 EH1_F_IH0_K_AE2_S_IY0 AH1_V P_R_AH0_P_OW1_Z_D T_R_IY1_T_M_AH0_N_T_S AH1_V R_UW1_M_AH0_T_OY2_D AA0_R_TH_R_AY1_T_AH0_S It HH_AE1_Z B_IH1_N Y_UW1_T_AH0_L_AY2_Z_D IH0_N AO1_R_D_ER0 T_UW1 K_AH0_N_F_ER1_M DH_AH0 EH1_F_IH0_K_AE2_S_IY0 AH1_V tocilizumab     AH0_N_D infliximab    